Medtronic begins trial of second generation stent:
This article was originally published in Clinica
Executive Summary
Medtronic is starting a US clinical trial of its Talent LPS endoluminal stent for treating abdominal aortic aneurysms. The second-generation stent is made from thinner graft material than its predecessor, making it easier to implant, says Medtronic. The trial will involve 100 patients at 13 medical centres. The stent, which is made by the company's Sunrise, Florida-based subsidiary World Medical Manufacturing, has been available in Europe since November 1998.